Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The top clinical trial opportunities in therapeutic apheresis and neurology.
Alemtuzumab and multiple sclerosis: Is it safe?
Bone Marrow-Derived Stem Cells and Strategies for Treatment of Nervous System Disorders: Many Protocols, and Many Results.
Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.
Oral BG-12 in multiple sclerosis.
Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.
Danish translation and psychometric testing of the Rivermead Mobility Index.
Criteria improving multiple sclerosis diagnosis at the first MRI.
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.
Identification of Dominant Human Aquaporin 4 T-Cell Epitopes: Observations in Neuromyelitis Optica With Implications for Other Autoimmune DisordershAQP4 T-Cell Epitopes.
Multiple sclerosis: Spinal cord MRI indices correlate with outcome in MS.
Unusual symptoms and syndromes in multiple sclerosis.
Neuroborreliosis during natalizumab treatment in multiple sclerosis.
Erratum to "Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics"
ISENTRESS® prescribing information
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair.
[Multiple sclerosis.]
Tumefactive demyelination presenting during bevacizumab treatment.
Sodium channel Nav1.8: Emerging links to human disease.
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.

Pages